Objective: This study aimed to determine the natural history of spontaneous isolated abdominal aortic dissection (SIAAD) and to establish an optimal management strategy for patients with SIAAD.
Aortic dissection (AD) often affects the thoracic aorta and has received much attention from cardiologists and aortic surgeons. Isolated abdominal aortic dissection (IAAD) is rarely reported as having a potential risk of aortic rupture, acute visceral or leg ischemia, or neurologic symptoms such as paraplegia. 1 Most of the previous reports on IAAD were retrospective reviews of a small number of symptomatic patients or case series regarding successful surgical or endovascular treatment.
In the International Registry of Acute Aortic Dissection (IRAD), 18 (1.3%) patients with isolated acute abdominal aortic dissection (IAAAD) were reported among 1417 patients with acute AD. 2 On the basis of IRAD data, the patients with IAAAD showed abdominal pain, mesenteric ischemia, and limb ischemia more frequently compared with patients with type B dissection. Accordingly, continued surveillance appears to be mandatory, and aggressive surgical or endovascular management seems justified to improve the life expectancy of patients with IAAAD. Clinical features, expansion rate, predictors of aortic growth or aortic rupture, and optimal treatment strategies have been well described for patients with thoracic AD. [3] [4] [5] On the other hand, IAAD has been reported much less frequently, and its natural history or optimal management has not yet been well established. When iatrogenic or traumatic AD is excluded from the IAAD, the entity is termed spontaneous IAAD (SIAAD).
There has been no debate on the treatment of IAAD with aortic rupture or visceral or leg ischemic symptoms. However, there have been various suggestions for management of noncomplicated, asymptomatic SIAAD ranging from early prophylactic interventions to conservative management. 6, 7 Advocates for early prophylactic interventions are concerned about the risk of aortic rupture, visceral ischemia, or leg ischemia in SIAAD patients. [8] [9] [10] There is not sufficient evidence to support either early prophylactic intervention or conservative treatment for patients with noncomplicated SIAAD.
In this study, we sought to determine the clinical characteristics and natural history of SIAAD and to establish an optimal treatment strategy for such patients based on the natural history of the disease.
METHODS
Enrollment of patients. SIAAD was defined as a spontaneous AD confined to the abdominal aorta regardless of its extension to a visceral or iliac artery and not due to a traumatic or iatrogenic cause. This study was approved by the Institutional Review Board of Samsung Medical Center, and obtaining informed consent from patients was waived for this retrospective review. We searched SIAAD patients from the database of patients who underwent contrast-enhanced thoracoabdominal computed tomography (CT) scans at a single institution from January 2003 to July 2016 using keywords of "aortic dissection" and "dissection AND aorta." After excluding thoracic ADs and traumatic or iatrogenic ADs (Fig 1) , we reviewed all CT images of the remaining patients to confirm the presence of a typical AD flap in the abdominal aorta. For a diagnosis of AD to be made, a typical double lumen on the axial view of contrastenhanced aortic CT images was identified. We excluded patients showing intramural hematoma (defined as the presence of a regionally thickened aortic wall in the absence of a double lumen and intimal flap) or penetrating atherosclerotic ulcers (defined as atherosclerotic plaques that ulcerate and disrupt the internal elastic lamina). 11, 12 For patients thought to have connective tissue disease (CTD), a diagnosis of Marfan syndrome was made on the basis of the revised Ghent nosology with or without presence of a bonafide FBN1 mutation. 13 If Ehlers-Danlos syndrome was suspected on the basis of the clinical and radiologic findings, diagnosis was confirmed with genomic DNA extracted from peripheral blood leukocytes with the Wizard Genomic DNA Purification Kit (Promega, Madison, Wisc). 14 Data collection. Study patients' demographics, clinical features, symptom status, coexisting disease or atherosclerotic risk factors, and AD-related events were retrieved from the electronic medical records. To compare characteristics of the patients, frequencies of clinical events, and late morphologic changes of AD, we classified the patients by symptom status (symptomatic vs asymptomatic), location of AD at initial presentation (infrarenal vs suprarenal), and gender. Death and cause of death of patients with SIAAD were confirmed from the Causes of Death Statistics in Statistics Korea. On the initial CT images, we determined the length, diameter, and location of the AD; involvement of the visceral branches; degree of aortic wall calcification; and direction of entry site of AD on aortic circumference. To classify the location of AD, infrarenal AD was defined as AD not involving the renal artery orifice; paravisceral AD was defined as AD involving the renal, superior mesenteric, or celiac artery; and supraceliac AD was defined as abdominal AD extended to the supraceliac segment of the aorta not involving thoracic aorta.
ARTICLE HIGHLIGHTS
Morphologic changes of the AD during the follow-up period were assessed by comparing the initial CT image with the last follow-up CT image in terms of false lumen enlargement, distal or proximal progression of the AD, false lumen thrombosis, remodeling of the dissected aorta, and extension to the visceral or iliac artery. The length of AD was calculated on the axial view of CT images by multiplying the number of slices showing a double lumen by the slice thickness (2 or 3 mm). To assess enlargement of the false lumen, the maximal orthogonal diameter of the largest portion of AD was measured on an axial view of a CT image using an electronic caliper, and then we compared the diameters in the initial and last CT images. Complete remodeling was defined if there was no dissection or aortic luminal narrowing found on the follow-up CT images. We analyzed characteristics of the patients, frequencies of clinical events (aortic rupture, aortic intervention, allcause and aorta-related mortality), and morphologic changes (false lumen enlargement, progression, remodeling of AD, and involvement of iliac or visceral artery) during the follow-up period according to the location of AD (infrarenal vs suprarenal), symptom status (symptomatic vs asymptomatic), and gender. Statistical analysis. Data are expressed as frequencies and percentages, means 6 standard deviations, or medians with interquartile ranges (IQRs) and compared using the Mann-Whitney test, c 2 test, and Fisher exact test between two groups. Kaplan-Meier survival curves were used for demonstrating the cumulative incidence of clinical events and adverse morphologic changes. In all statistical tests, significant variance was determined at a P < .05 level using SPSS software (PC version 23.0; IBM Corp, Armonk, NY).
RESULTS
During the study period from January 2003 to July 2016, there were 1958 patients with AD identified with keyword searching from the database of thoracoabdominal CT image interpretations. Excluding thoracic AD (n ¼ 1742) and traumatic or iatrogenic abdominal AD (n ¼ 6), 210 (10.7%) SIAAD patients were enrolled for further analysis. Among 210 SIAAD patients, follow-up CT images were available for 138 (65.7%) patients during the median follow-up period of 25 months (range, 1-158 months; IQR, 12.3-49.1 months; Fig 1) . Patients who underwent follow-up studies with some other imaging modality, such as duplex ultrasound or non-contrastenhanced CT, were excluded from the analysis.
The demographic and clinical features of SIAAD patients are shown in Table I . The median age of the patients was 69.4 years (IQR, 61.3-74.7 years), and the . Of all SIAAD patients, 28 (13.3%) were symptomatic at initial presentation, including sudden-onset abdominal pain in all patients with back pain (n ¼ 9), chest pain (n ¼ 1), foot coldness (n ¼ 1), or findings of multiorgan failure due to visceral artery malperfusion (n ¼ 1). All symptomatic patients in this study showed acute onset of symptoms within 2 weeks. The identified coexisting disease or atherosclerotic risk factors were hypertension, renal cysts, and abdominal aortic aneurysm (AAA) in 62.9%, 40.5%, and 16.7%, respectively. Five patients had past history of vasculitis, which included Takayasu arteritis (n ¼ 4) and Kawasaki disease (n ¼ 1). Four patients had CTD that included Marfan syndrome (n ¼ 2) and type IV EhlersDanlos syndrome (n ¼ 2; Table I ). All four patients with CTD were female, and two patients (50%) had suprarenal AD. Also, three patients (75%) were symptomatic at the initial presentation.
Morphologic features of SIAAD at the initial presentation are shown in Table II . The median length of SIAAD was 18 mm (range, 6-290 mm; IQR, 10-30.5 mm). The SIAAD was most often located at the infrarenal aorta (87.6%), followed by the supraceliac (8.6%) and paravisceral (3.8%) aorta. On the initial CT images, AD extended to the iliac artery (12.4%) and to the visceral arteries in 2.4%, including three (1.4%) superior mesenteric and three (1.4%) renal arteries. Aortic wall calcification around the AD lesion was <50% of the aortic wall circumference in 96% of patients. Regarding pathogenesis of SIAAD, we hypothesized that aortic wall calcification affects initiation or protection of the AD. However, we found no significant association between SIAAD and amount of aortic wall calcification. The direction of the entry site of AD did not show any predilection around the aortic wall circumference (Table II) .
The results regarding comparison of patients' characteristics and frequencies of clinical events or morphologic changes during the follow-up period by location of AD are shown in Table III . Female gender, presence of symptoms, visceral artery involvement, aorta-related mortality, and false lumen enlargement were more common in the suprarenal AD group than in the infrarenal AD group (Table III) . When the variables were compared between symptomatic and asymptomatic groups, we found that younger age, female gender, CTD, visceral artery involvement, and aorta-related mortality were more frequently associated with symptomatic SIAAD than its asymptomatic counterpart (Table IV) . On the comparison by gender, the results showed that younger age, suprarenal AD, history of vasculitis, CTD, visceral artery involvement, and aorta-related mortality were more frequently associated with female patients than with male patients (Table V) .
By analyzing the patients excluding those with CTD, we found differences in the patients' characteristics on the comparison by location of AD, symptom status, and gender difference. However, there was no significant difference in frequencies of clinical events or late morphologic changes (Supplementary Tables I-III, online only) . Fig 2 shows a Kaplan-Meier curve demonstrating the cumulative incidence of clinical events including aortic rupture, aorta-related mortality, and aortic intervention during the follow-up period. Among 138 patients with follow-up CT images, morphologic changes of AD showed no change or remodeling in 81.9%, false lumen enlargement in 8.7%, progression of AD in 6.5%, and iliac extension in 0.8%. However, there was no newly developed visceral artery extension during the follow-up period. Interestingly, there was complete remodeling of AD in 1.4% of SIAAD patients. Fig 3 shows a Kaplan-Meier curve of cumulative incidence of adverse morphologic changes of AD including false lumen enlargement, progression of AD, and extension to the iliac artery during the follow-up period.
Comparison of patients' characteristics and late outcomes by gender is shown in Table V . We found that female SIAAD patients were younger and were more likely to have presence of symptoms, vasculitis, CTD, suprarenal AD, iliac artery involvement, and higher aorta-related mortality than male patients. However, there was no significant difference in the late morphologic changes between the two groups. Even though we compared those two groups after excluding four CTD patients from the female group, the results remained the same, although the female group no longer showed an association with aortic rupture or aorta-related mortality.
During the study period, five patients with SIAAD underwent elective AAA repair (one open repair, four endovascular repairs) because of the large diameter (>5 cm) of concurrent AAA at initial presentation. Among 12 (8.7%) patients showing false lumen enlargement on follow-up CT examination, 1 developed aortic rupture resulting in death, 1 underwent aortic open repair, and the remaining 10 patients are under surveillance. Among nine (6.5%) patients showing longitudinal progression (four distal and five proximal), one patient was a rupture case and the remaining eight patients are under surveillance so far. One patient who developed aortic rupture showed both false lumen enlargement and longitudinal progression of AD.
During the follow-up period, 35 (16.7%) deaths were identified from the Causes of Death Statistics in Statistics Korea. Among them, three aorta-related deaths were attributed to two aortic ruptures and one multiple organ failure due to acute visceral organ malperfusion. The other causes of death during the follow-up period were malignant disease (n ¼ 25), cardiacrelated death (n ¼ 2), respiratory failure (n ¼ 2), gastrointestinal bleeding due to gastric cancer (n ¼ 1), septic shock of unknown origin (n ¼ 1), and other unidentified cause (n ¼ 1). DISCUSSION SIAAD is a rare disease entity with a reported incidence of <2% of all patients with AD. 10 The IRAD reported 18
( (Table VI) . However, other authors reported a higher frequency of asymptomatic patients. 8, 15 The proportion of symptomatic patients or frequency of aortic rupture or visceral artery ischemia can vary, depending on the method of patient enrollment. Contrary to the previous reports, we found that a smaller portion (13.3%) of SIAAD patients were symptomatic at initial presentation, with a lower prevalence of coexisting AAA (16.7%) or visceral organ malperfusion (0.5%). This difference may be attributed to a large number of asymptomatic patients identified by keyword searching. As in our study, 8.7% of patients with abdominal AD were found to have pre-existing infrarenal AAA in a recent study from China. 19 Mozes et al 9 reviewed 41 English studies and reported that 14% of SIAAD patients presented with aortic rupture. They recommended elective repair of SIAAD, considering the high mortality rate in case of aortic rupture. Also in a meta-analysis of 92 patients including 73 (79%) SIAAD patients, Jonker et al 27 reported a 10% incidence of aortic rupture and higher mortality and complication rates in patients receiving conservative treatment than in patients who underwent interventional treatment with either open or endovascular repair. However, there were many authors who recommended selective surgical or endovascular treatment in cases of aortic rupture, presence of refractory pain or symptoms associated with visceral or lower limb ischemia, or aneurysmal change.
1, 28 Bockler et al 8 reported treatment of 18 patients with SIAAD including 10 asymptomatic patients who underwent conservative management. According to them, the majority of patients with SIAAD eventually require invasive treatment; endovascular treatment can be a preferable treatment option today. Because aortic enlargement resulting in rupture is the most worrisome complication of SIAAD, the morphologic changes of AD during long-term follow-up have been the focus of follow-up examinations even in patients with focal and small-diameter AD. Considering the possibility of sudden development of morphologic changes or clinical events, we included all SIAAD patients who underwent clinical follow-up and CT examinations regardless of the duration of follow-up.
In our series, we found that clinical or significant morphologic changes developed only in a small number of patients during the follow-up period.
Currently, there are several reports describing good long-term results after endovascular treatment of SIAAD. 6, 15, 19, 29 According to these studies, the treatment result of SIAAD is superior in patients with chronic, asymptomatic AD compared with patients with acute or symptomatic AD. Symptomatic patients naturally seek interventional treatment. However, it is still not known how to identify good candidates for earlier, more proactive, interventional treatment of patients with chronic, asymptomatic SIAAD.
To find any difference in clinical features or frequency of morphologic changes, we compared infrarenal vs Table VI . Demographic and clinical features of spontaneous isolated abdominal aortic dissection (SIAAD) patients reported in previous studies suprarenal ADs, asymptomatic vs symptomatic ADs, and male vs female patients. As we anticipated, visceral artery involvement is more likely in patients with suprarenal AD compared with infrarenal AD. Furthermore, surgical or endovascular treatment is more challenging in patients with suprarenal AD. When the patients' initial characteristics were compared between infrarenal and suprarenal AD groups, we found that female gender, presence of symptoms, and visceral artery involvement were more common in the suprarenal AD group. They also showed higher aorta-related mortality compared with those in the infrarenal AD group. Based on the comparison of frequencies of clinical events or late morphologic changes between infrarenal and suprarenal SIAAD, false lumen enlargement was more frequent in suprarenal SIAAD than in the infrarenal group before and after exclusion of CTD patients (5.7% vs 30.7%; P ¼ .012; Table III;  Supplementary Table I , online only).
Zhu et al 19 reported different characteristics of patients among supraceliac, paravisceral, and infrarenal AD groups. Specifically, they reported that the mean age of patients in the supraceliac and paravisceral AD groups was younger than in the infrarenal group. However, in our study, there was no significant difference in age between infrarenal and suprarenal AD groups (median age, 70.5 vs 69.2 years; P ¼ .948). In our study, three aorta-related deaths occurred because of visceral malperfusion (n ¼ 1) at the initial presentation and aortic rupture in two patients with type IV Ehlers-Danlos syndrome during the study period. Aorta-related mortality was more common in symptomatic patients (n ¼ 28; 7.1% vs 0.5%; P ¼ .047). Among symptomatic SIAAD patients, only one patient underwent elective endovascular aortic aneurysm repair because of unrelieved persistent back pain when the aortic diameter was 38 mm. The initial symptoms disappeared in a few days in the majority of patients. Although symptomatic SIAAD seemed more likely to be associated with younger age, female gender, CTD, visceral artery involvement, and aorta-related mortality, this finding was not consistent when we excluded the patients with CTD (Supplementary Table II , online only). We think not all symptomatic patients require early aortic intervention.
It has been generally accepted that aortic aneurysm or AD secondary to Marfan syndrome requires earlier surgical treatment than for patients with other degenerative aneurysms or AD. 30 The two aortic ruptures in this study developed only in patients with type IV Ehlers-Danlos syndrome at the time of aortic diameter of 28 mm and 21 mm. Because of the risk of aortic rupture for such patients, early intervention may be acceptable even in patients with small aortic diameter. However, because high surgical risk and poor prognosis of both open surgical and endovascular treatment are well known for patients with Ehlers-Danlos syndrome, we cannot currently suggest a proper management strategy for those patients. The limitations of our study are its retrospective design and low follow-up rate. In addition, our cohort included patients with both acute and chronic abdominal AD. The major problem of this study is that no power analysis was performed because of the small numbers of patients and events. Because of these limitations, we cannot 
CONCLUSIONS
In SIAAD patients, visceral or iliac artery involvement was uncommon, and the majority of SIAAD patients showed no significant change in clinical or morphologic features during follow-up, with low (1.4%) disease-specific mortality. On the basis of our observations, we recommend that asymptomatic infrarenal SIAAD be conservatively managed with the same surgical indications as for nonruptured degenerative AAA unless it is associated with CTD. However, a more proactive management strategy may be required in female, symptomatic patients with SIAAD, in particular those with suprarenal AD. Risk vs benefit of the therapeutic intervention should be clarified before treatment is decided for patients with SIAAD. Additional material for this article may be found online at www.jvascsurg.org.
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The authors report the largest single-center experience with spontaneous isolated abdominal aortic dissection. Although abdominal aortic dissection is not common, the potential for life-and limb-threatening complications, including paraplegia, visceral or leg ischemia, and aortic rupture, has prompted recommendations for aggressive follow-up and intervention.
There have been several recent single-center reports on isolated abdominal dissection in addition to the International Registry of Acute Aortic Dissection, but most have focused on the role and advantages of endovascular therapy in treating the condition. Few have sufficient longterm follow-up and numbers of patients to provide recommendations regarding the more fundamental issued whether intervention should be undertaken at all. Although retrospective and from a single center, the current report provides some of the best available data in defining the natural history and risk factors for complications.
This study defines the expected growth rate of aortic diameter and, more importantly, finds that except for selected groups, prophylactic intervention is not warranted unless the aorta reaches 6 cm in size, similar to currently accepted indications for intervention with an unruptured abdominal aortic aneurysm. The conclusion that women should undergo intervention at a smaller diameter and that individuals with a connective tissue disease should be more closely monitored seems reasonable. More importantly, only those individuals with the development of a branch vessel involvement leading to organ system ischemia or aortic rupture, or women with symptomatic suprarenal disease warrant intervention. I support this approach, agree with the authors' conclusions, and suspect its widespread acceptance will reduce the number of unnecessary aortic procedures, endovascular or open.
It is important to note that two patients, both with Ehlers-Danlos syndrome, had aortic rupture at initial presentation with an aortic diameter of <3 cm. However, no ruptures occurred during follow-up of the 210 patients. This supports the recommendation for annual imaging follow-up, and if undertaken with duplex scan, will further reducing unnecessary testing and cost. The relatively benign natural history should serve to reassure patients and physicians alike of the relatively low incidence of complications from spontaneous isolated dissection of the abdominal aorta and the ability of complications to be identified and treated with low morbidity and mortality. Further refinement on the indications for intervention in individuals with connective tissue disease, women, and patients with suprarenal involvement is still needed.
The opinions or views expressed in this commentary are those of the authors and do not necessarily reflect the opinions or recommendations of the Journal of Vascular Surgery or the Society for Vascular Surgery. 
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